Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma of lung
|
1204 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.100 | 0.813 | 16 | 2004 | 2019 | |||||
Malignant neoplasm of lung
|
1142 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.100 | 0.813 | 16 | 2004 | 2019 | |||||
Primary malignant neoplasm of lung
|
981 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.100 | 0.813 | 16 | 2004 | 2019 | |||||
Breast Carcinoma
|
2793 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.100 | 0.750 | 12 | 2004 | 2018 | |||||
Malignant neoplasm of breast
|
3417 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.100 | 0.750 | 12 | 2004 | 2018 | |||||
Colorectal Carcinoma
|
1962 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.090 | 0.778 | 9 | 2008 | 2017 | |||||
Malignant Neoplasms
|
1641 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.060 | 0.833 | 6 | 2005 | 2015 | |||||
Primary malignant neoplasm
|
1374 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.050 | 0.800 | 5 | 2005 | 2013 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.040 | 0.750 | 4 | 2008 | 2017 | |||||
Bladder Neoplasm
|
281 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.030 | 0.667 | 3 | 2007 | 2013 | |||||
Carcinoma of bladder
|
309 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.030 | 0.667 | 3 | 2007 | 2013 | |||||
Malignant neoplasm of prostate
|
1082 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.030 | 1.000 | 3 | 2014 | 2016 | |||||
Malignant neoplasm of stomach
|
615 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.030 | 1.000 | 3 | 2009 | 2013 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.030 | 0.667 | 3 | 2007 | 2013 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||
Prostate carcinoma
|
1168 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.030 | 1.000 | 3 | 2014 | 2016 | |||||
Stomach Carcinoma
|
652 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.030 | 1.000 | 3 | 2009 | 2013 | |||||
Adenocarcinoma of lung (disorder)
|
563 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Alzheimer's Disease
|
1843 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.020 | 1.000 | 2 | 2008 | 2017 | |||||
Endometriosis
|
274 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.020 | 1.000 | 2 | 2010 | 2015 | |||||
Malignant neoplasm of gastrointestinal tract
|
55 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.020 | 0.500 | 2 | 2015 | 2015 | |||||
Neoplasms
|
1644 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Parkinson Disease
|
990 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.020 | 1.000 | 2 | 2012 | 2017 | |||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.020 | 0.500 | 2 | 2012 | 2014 | |||||
Adenocarcinoma
|
168 | 0.555 | 0.720 | 14 | 20456995 | missense variant | T/A;C;G | snv | 4.0E-06; 4.0E-06; 0.42 | 0.010 | 1.000 | 1 | 2010 | 2010 |